Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-24 @ 9:14 PM
NCT ID:
NCT03402204
Eligibility Criteria:
Inclusion Criteria:
* Patient with acute ischemic stroke has symptom onset less than 24 hours.
* Patient has 18 to 85 years old.
* Patient has been obtained describe the study and sign on informed consent.
Exclusion Criteria:
* Patient has indication for simvastatin or ya-hom-navakote.
* Patient has pre-stroke mRS score more than 1.
* Patient was enrolled in other study within 30 days ago.
* Researchers consider that could be harmed by the participants or have certain conditions that could affect the participation in research, such as last stage of cancer.
* According to medical research suggests that patients unable to cooperate in research or inappropriate in joint research with other causes.
* Conscious level has \>2 scores on question 2 of NIHSS.
* Platelet counts have less than 100,000 cells per cubic milliliter.
* Hematocrit has less than 0.25
* Blood sugar (BS) has less than 60 mg/dl or more than 200 ml/dl or between 200 and 300 mg/dl and treated with diabetes drug until the BS levels have less than 200 mg/dl can include for the project before receive the researched drug.
* Patient with uncontrolled hypertension by measure systolic blood pressure (SBP) has more than 200 mmHg and/or diastolic blood pressure (DBP) has more than 110 mmHg before receive the researched drug or patient that receive aggressive treatment.
* Patient with others stroke or severe head injury within 6 weeks before enrolled to the project.
* Patient is received severe surgery within 14 days before enrolled to the project.
* Patient has seizure with acute ischemic stroke.
* Patient has acute myocardial infarction (AMI) or coronary heart disease (CHD) within 3 weeks before enrolled to the project.
* Patient who receives lower-lipid level drug i.e. Ezetrol, Fenofibrate, Gemfibrosil, and Niacin or statin drugs i.e. Atorvastatin and Pitavastatin.
* Patient has increasing liver enzyme level or liver abnormal disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03402204
Study Brief:
Protocol Section:
NCT03402204